GLP-1 Withdrawal Can Have Lasting Health Effects

“While many patients can shed up to 20% of their body weight using the injectables, the cost of the drugs and side effects like nausea and vomiting lead many to qui within one year of withdrawal, the participants in a 2022 study]regained two-thirds of their prior weight loss, with corresponding changes in risks for conditions like heart disease and Type 2 diabetes.” 

Continue reading GLP-1 Withdrawal Can Have Lasting Health Effects

Zepbound Could Become Biggest Single Cost Driver For Employer Sponsored Health Plans

Lilly’s Obesity Drug Zepbound To Be Key 2025 Health Cost Driver

Bruce Japsen – Senior Contributor – Bruce Japsen writes about healthcare business and policy.

Jan 1, 2025

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers, employers and government health programs that cover it this year.

Continue reading Zepbound Could Become Biggest Single Cost Driver For Employer Sponsored Health Plans